Search company, investor...

Executives

4

Board of Directors

4

Blackthorn Therapeutics Management Team

4 Team Members

Blackthorn Therapeutics has 4 executives. Blackthorn Therapeutics's former Chief Executive Officer is Alex Tkachenko.

Name

Work History

Title

Status

Alex Tkachenko

Chief Executive Officer

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Alex Tkachenko

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Blackthorn Therapeutics Board of Directors

4 Board of directors

Blackthorn Therapeutics has 4 board of directors, including John MacPhee.

Name

Firm

Work History

Other Seats

John MacPhee

Blackthorn Therapeutics

Lori Hu

Lori Hu is a Managing Director at Vertex Ventures HC (VVHC), leading global healthcare investments based in San Francisco. She joined VVHC in 2015 as part of the founding team to establish a US presence and has led or co-led over a dozen investments across the biotech and medtech sectors. Lori serves on the board of directors for Indapta Therapeutics, Elevation Oncology (NASDAQ: ELEV), Neuspera Medical and Palleon Pharmaceuticals. She is a board observer for Moximed and previously served on the boards of Ivantis (acquired by Alcon for $475M) and Blackthorn (now Neumora). She supported Vertex’s investment in Twelve (acquired by Medtronic for $458 M). Before VVHC, Lori was an Associate Director for Business Development at Bristol-Myers Squibb, identifying and executing licensing and partnership transactions based in Shanghai. Previously, she was a strategy consultant at Accenture, advising biopharmaceutical clines on strategic projects across the US and Asia. Lori graduated with an MBA from The Wharton School, and MA in International Studies from the University of Pennsylvania. She also holds a BSE in Biomedical Engineering from Duke University.

Blackthorn Therapeutics

Mark Corrigan M D

Blackthorn Therapeutics

Matthew Fust

Blackthorn Therapeutics

Name

John MacPhee

Lori Hu

Mark Corrigan M D

Matthew Fust

Firm

Work History

Lori Hu is a Managing Director at Vertex Ventures HC (VVHC), leading global healthcare investments based in San Francisco. She joined VVHC in 2015 as part of the founding team to establish a US presence and has led or co-led over a dozen investments across the biotech and medtech sectors. Lori serves on the board of directors for Indapta Therapeutics, Elevation Oncology (NASDAQ: ELEV), Neuspera Medical and Palleon Pharmaceuticals. She is a board observer for Moximed and previously served on the boards of Ivantis (acquired by Alcon for $475M) and Blackthorn (now Neumora). She supported Vertex’s investment in Twelve (acquired by Medtronic for $458 M). Before VVHC, Lori was an Associate Director for Business Development at Bristol-Myers Squibb, identifying and executing licensing and partnership transactions based in Shanghai. Previously, she was a strategy consultant at Accenture, advising biopharmaceutical clines on strategic projects across the US and Asia. Lori graduated with an MBA from The Wharton School, and MA in International Studies from the University of Pennsylvania. She also holds a BSE in Biomedical Engineering from Duke University.

Other Seats

Blackthorn Therapeutics

Blackthorn Therapeutics

Blackthorn Therapeutics

Blackthorn Therapeutics

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.